Panbela Therapeutics Inc (PBLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PBLA | AZN | AMGN | GILD | BMY |
| Company | Panbela Therapeutics Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | OTC US | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 0.0111 | 169.84 | 372.73 | 130.93 | 61.94 |
| High | 0.0111 | 170.26 | 379.41 | 131.65 | 62.82 |
| Low | 0.0111 | 168.33 | 372.16 | 129.44 | 61.60 |
| Latest | 0.0111 | 168.82 | 376.48 | 129.97 | 62.13 |
| Change | unch | +0.55 | +4.98 | -0.89 | +0.62 |
| % Change | unch | +0.33% | +1.34% | -0.68% | +1.01% |
| Volume | 2,200 | 1,019,136 | 1,128,729 | 2,200,071 | 4,857,959 |
| 20-Day Average Volume | 1,185 | 2,699,293 | 2,218,261 | 7,221,928 | 10,627,272 |
| Previous Close | 0.0111 | 168.27 | 371.50 | 130.86 | 61.51 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.0064 | 177.60 | 365.16 | 131.14 | 58.89 |
| 20-Day Raw Stochastic | 100.00% | 15.04% | 91.73% | 35.81% | 91.98% |
| 20-Day Relative Strength | 51.04 | 42.38 | 62.28 | 49.21 | 61.04 |
| Weighted Alpha | -5.31 | +5.37 | +25.42 | +8.64 | +31.01 |
| Today's Opinion | 72% Sell | 88% Sell | 88% Buy | 40% Sell | 72% Buy |
| Previous Opinion | 72% Sell | 88% Sell | 72% Buy | 24% Sell | 72% Buy |
| Last Month's Opinion | 72% Sell | 40% Sell | 40% Buy | 72% Sell | 24% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +122.00% since 06/26/26 | +0.01% since 07/17/26 | +3.01% since 07/17/26 | -3.14% since 07/17/26 | +2.44% since 07/17/26 |
| Low | 0.0111 on 07/21/26 | 164.06 on 07/20/26 | 359.21 on 07/23/26 | 127.61 on 07/23/26 | 59.80 on 07/21/26 |
| High | 0.0111 on 07/21/26 | 170.89 on 07/22/26 | 379.41 on 07/24/26 | 135.50 on 07/20/26 | 62.82 on 07/24/26 |
| 1-Month | |||||
| %Chg | unch since 06/18/26 | -7.70% since 06/24/26 | +7.36% since 06/24/26 | +3.92% since 06/24/26 | +13.14% since 06/24/26 |
| Low | 0.0002 on 06/24/26 | 164.06 on 07/20/26 | 350.06 on 06/25/26 | 123.67 on 06/25/26 | 55.02 on 06/25/26 |
| High | 0.0111 on 07/21/26 | 196.41 on 07/02/26 | 379.41 on 07/24/26 | 140.61 on 07/17/26 | 62.82 on 07/24/26 |
| 3-Month | |||||
| %Chg | unch since 04/21/26 | -10.97% since 04/24/26 | +9.51% since 04/24/26 | -0.25% since 04/24/26 | +5.99% since 04/24/26 |
| Low | 0.0002 on 06/24/26 | 164.06 on 07/20/26 | 320.52 on 05/05/26 | 121.39 on 06/10/26 | 53.44 on 06/18/26 |
| High | 0.0111 on 07/21/26 | 196.41 on 07/02/26 | 379.41 on 07/24/26 | 140.61 on 07/17/26 | 62.82 on 07/24/26 |
| 6-Month | |||||
| %Chg | +1,010.00% since 01/21/26 | -9.13% since 01/23/26 | +9.44% since 01/23/26 | -4.31% since 01/23/26 | +13.86% since 01/23/26 |
| Low | 0.0002 on 06/24/26 | 164.06 on 07/20/26 | 320.52 on 05/05/26 | 121.39 on 06/10/26 | 53.44 on 06/18/26 |
| High | 0.1000 on 02/27/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 54 | 260,971,280 | 200,501,520 | 162,471,840 | 125,607,792 |
| Shares Outstanding, K | 4,855 | 1,550,908 | 539,708 | 1,241,570 | 2,042,071 |
| Annual Sales | 0 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -25,260,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 0 | 15,288,000,000 | 8,618,000,000 | 6,960,000,000 | 11,489,000,000 |
| Last Quarter Net Income | -7,170,000 | 3,080,000,000 | 1,819,000,000 | 2,021,000,000 | 2,677,000,000 |
| 60-Month Beta | 42.64 | 0.24 | 0.41 | 0.32 | 0.23 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A on 11/09/23 | 2.58 on 04/29/26 | 5.15 on 04/30/26 | 2.03 on 05/07/26 | 1.58 on 04/30/26 |
| Earnings Date | 01/01/26 | 07/27/26 | 08/04/26 | 08/04/26 | 07/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 05/15/26 | 0.820 on 06/15/26 | 0.630 on 07/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 06/15/26 | 07/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 18.33 | 16.56 | 15.57 | 10.25 |